Mangalam Drugs & Organics Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,321	3,176	3,674	3,702	4,509
Other Revenue	7.63	-	-	-	-
Revenue	2,329	3,176	3,674	3,702	4,509
Revenue Growth (YoY)	-26.66%	-13.55%	-0.77%	-17.89%	18.66%
Cost of Revenue	1,569	1,702	2,472	2,536	3,101
Gross Profit	760.2	1,474	1,201	1,166	1,408
Selling, General & Admin	337.88	421.82	403.56	359.68	396.96
Other Operating Expenses	563.73	690.5	623.42	550.29	520.32
Operating Expenses	1,084	1,278	1,173	1,020	1,020
Operating Income	-323.63	195.61	27.98	146.34	387.99
Interest Expense	-162.08	-111.8	-104.09	-89.21	-72.02
Interest & Investment Income	-	0.58	0.96	2.98	0.01
Other Non Operating Income (Expenses)	0	-37.27	-35.06	-37.94	-39.59
EBT Excluding Unusual Items	-485.71	47.12	-110.21	22.17	276.37
Gain (Loss) on Sale of Investments	-	-	-	-	0.89
Gain (Loss) on Sale of Assets	-	0.74	-0.52	-0.03	-
Pretax Income	-485.71	47.86	-110.73	22.14	277.33
Income Tax Expense	-41.71	-19.35	-20.02	9.44	80.76
Net Income	-444	67.21	-90.72	12.7	196.58
Net Income to Common	-444	67.21	-90.72	12.7	196.58
Net Income Growth	-	-	-	-93.54%	-29.72%
Shares Outstanding (Basic)	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16
Shares Change (YoY)	0.00%	-	-	-	-
EPS (Basic)	-28.05	4.25	-5.73	0.80	12.42
EPS (Diluted)	-28.05	4.25	-5.73	0.80	12.42
EPS Growth	-	-	-	-93.56%	-29.72%
Free Cash Flow	-77.22	223.93	-79.2	116.09	-19.6
Free Cash Flow Per Share	-4.88	14.15	-5.00	7.33	-1.24
Gross Margin	32.64%	46.41%	32.71%	31.50%	31.22%
Operating Margin	-13.90%	6.16%	0.76%	3.95%	8.61%
Profit Margin	-19.06%	2.12%	-2.47%	0.34%	4.36%
Free Cash Flow Margin	-3.32%	7.05%	-2.16%	3.14%	-0.43%
EBITDA	-141.4	330.21	76.84	241.08	473.58
EBITDA Margin	-6.07%	10.40%	2.09%	6.51%	10.50%
D&A For EBITDA	182.23	134.6	48.86	94.74	85.6
EBIT	-323.63	195.61	27.98	146.34	387.99
EBIT Margin	-13.90%	6.16%	0.76%	3.95%	8.61%
Effective Tax Rate	-	-	-	42.63%	29.12%
Revenue as Reported	2,329	3,187	3,687	3,727	4,512
Advertising Expenses	-	15.95	12.85	13.56	24.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.